Tic disorder possibly related to the duration of action of short-acting methylphenidate in a seven-year-old child with attention deficit hyperactivity disorder and intellectual disability
Abstract
Keywords
Methylphenidate , Intellectual Disability , Tic Disorder , Attention Deficit Hyperactivity Disorder , Child.
Kaynakça
- Neece CL, Baker BL, Crnic K, Blacher J. Examining the validity of ADHD as a diagnosis for adolescents with intellectual disabilities: Clinical presentation. J Abnorm Child Psychol. 2013;41:597-612.
- Perera B. Attention deficit hyperactivity disorder in people with intellectual disability. Ir J Psychol Med. 2018;35:213-9.
- Tarrant N, Roy M, Deb S, Odedra S, Retzer A, Roy A. The effectiveness of methylphenidate in the management of attention deficit hyperactivity disorder (ADHD) in people with intellectual disabilities: A systematic review. Res Dev Disabil. 2018;83:217-32.
- Miller J, Perera B, Shankar R. Clinical guidance on pharmacotherapy for the treatment of attention-deficit hyperactivity disorder (ADHD) for people with intellectual disability. Expert Opin Pharmacother. 2020;21:1897-913.
- Cohen SC, Mulqueen JM, Ferracioli-Oda E, Stuckelman ZD, Coughlin CG, Leckman JF et al. Meta-analysis: risk of tics associated with psychostimulant use in randomized, placebo-controlled trials. J Am Acad Child Adolesc Psychiatry. 2015;54:28-736.
- Ogundele MO, Ayyash HF. Review of the evidence for the management of co-morbid tic disorders in children and adolescents with attention deficit hyperactivity disorder. World J Clin Pediatr. 2018;7:36-42
- Herrik KF, Redrobe JP, Holst D, Hougaard C, Sandager-Nielsen K, Nielsen AN et al. CyPPA, a positive SK3/SK2 modulator, reduces activity of dopaminergic neurons, inhibits dopamine release, and counteracts hyperdopaminergic behaviors induced by methylphenidate. Front Pharmacol. 2012;3:11.
- Ihezie SA, Thomas MM, Dafny N. Acute and chronic methylphenidate administration in intact and VTA-specific and nonspecific lesioned rats. J Neural Transm (Vienna). 2019;126:173-82.
- Felling RJ, Singer HS. Neurobiology of tourette syndrome: current status and need for further investigation. J Neurosci. 2011;31:12387-95.
- Faraone SV.The pharmacology of amphetamine and methylphenidate: relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities. Neurosci Biobehav Rev. 2018;87:255–70.
